{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:17:19Z","timestamp":1788297439799,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plasticsurgery.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Plastic Surgery"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cps.2026.05.004","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:34:34Z","timestamp":1783539274000},"page":"529-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medical Management of Vascular Anomalies"],"prefix":"10.1016","volume":"53","author":[{"given":"Tishi","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise M.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cps.2026.05.004_bib1","unstructured":"ISSVA Classification of Vascular Anomalies \u00a92025 International Society for the Study of Vascular Anomalies Available at: \"issva.org\/classification\" Accessed April 5, 2026."},{"issue":"5","key":"10.1016\/j.cps.2026.05.004_bib2","doi-asserted-by":"crossref","first-page":"709e","DOI":"10.1097\/PRS.0000000000004294","article-title":"Vascular anomalies: from a clinicohistologic to a genetic framework","volume":"141","author":"Greene","year":"2018","journal-title":"Plast Reconstr Surg"},{"issue":"Suppl 3","key":"10.1016\/j.cps.2026.05.004_bib3","article-title":"How we approach the use of sirolimus and new agents: medical therapy to treat vascular anomalies","volume":"69","author":"Shimano","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.cps.2026.05.004_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/CIRCRESAHA.121.318145","article-title":"Genetic basis and therapies for vascular anomalies","volume":"129","author":"Queisser","year":"2021","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.cps.2026.05.004_bib5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in Tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cps.2026.05.004_bib6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pbc.23124","article-title":"Sirolimus for the treatment of complicated vascular anomalies in children","volume":"57","author":"Hammill","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.cps.2026.05.004_bib7","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3257","article-title":"Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies","volume":"137","author":"Adams","year":"2016","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.cps.2026.05.004_bib8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003088-200544080-00001","article-title":"Sirolimus: the evidence for clinical pharmacokinetic monitoring","volume":"44","author":"Stenton","year":"2005","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"10.1016\/j.cps.2026.05.004_bib9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology--drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.cps.2026.05.004_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26470","article-title":"Developmental pharmacokinetics of sirolimus: implications for precision dosing in neonates and infants with complicated vascular anomalies","volume":"64","author":"Mizuno","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.cps.2026.05.004_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13023-024-03243-5","article-title":"Long-term safety and influence on growth in patients receiving sirolimus: a pooled analysis","volume":"19","author":"Wang","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.cps.2026.05.004_bib13","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cps.2026.05.004_bib14","doi-asserted-by":"crossref","unstructured":"Trenor Iii CC, Adams DM, SpringerLink. Vascular Anomalies: A Guide for the Hematologist\/Oncologist. 1st 2020. ed. Springer International Publishing: Imprint: Springer; 2020.","DOI":"10.1007\/978-3-030-25624-1"},{"issue":"1","key":"10.1016\/j.cps.2026.05.004_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s13023-021-01929-8","article-title":"A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations","volume":"16","author":"Canaud","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.cps.2026.05.004_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1084\/jem.20181353","article-title":"Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly","volume":"216","author":"Rodriguez-Laguna","year":"2019","journal-title":"J Exp Med"},{"issue":"7711","key":"10.1016\/j.cps.2026.05.004_bib17","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","article-title":"Targeted therapy in patients with PIK3CA-related overgrowth syndrome","volume":"558","author":"Venot","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cps.2026.05.004_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1158\/1078-0432.CCR-23-1270","article-title":"FDA approval summary: alpelisib for PIK3CA-Related overgrowth spectrum","volume":"30","author":"Singh","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.cps.2026.05.004_bib19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ajhg.2017.01.018","article-title":"Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation","volume":"100","author":"Couto","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.cps.2026.05.004_bib20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2020.06.022","article-title":"Endothelial MAP2K1 mutations in arteriovenous malformation activate the RAS\/MAPK pathway","volume":"529","author":"Smits","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.cps.2026.05.004_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.sempedsurg.2024.151422","article-title":"Complex lymphatic anomalies: molecular landscape and medical management","volume":"33","author":"Borst","year":"2024","journal-title":"Semin Pediatr Surg"},{"issue":"1","key":"10.1016\/j.cps.2026.05.004_bib22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jpeds.2012.06.044","article-title":"Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals","volume":"162","author":"Croteau","year":"2013","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.cps.2026.05.004_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bvth.2025.100112","article-title":"Impact of anticoagulation on quality of life in patients with slow-flow vascular malformations","volume":"3","author":"Mack","year":"2026","journal-title":"Blood Vessel Thromb Hemost"},{"issue":"3","key":"10.1016\/j.cps.2026.05.004_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102402","article-title":"Anticoagulation and vascular anomalies","volume":"8","author":"Crary","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"Suppl 3","key":"10.1016\/j.cps.2026.05.004_bib25","article-title":"How we approach coagulopathy with vascular anomalies","volume":"69","author":"Mack","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.cps.2026.05.004_bib26","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/lrb.2017.0029","article-title":"Effectiveness and safety of treatment with direct oral anticoagulant rivaroxaban in patients with slow-flow vascular malformations: a case series","volume":"16","author":"Mack","year":"2018","journal-title":"Lymphatic Res Biol"},{"issue":"2 Suppl","key":"10.1016\/j.cps.2026.05.004_bib27","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral anticoagulants: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.cps.2026.05.004_bib28","article-title":"Medication-related impacts on pediatric bone health","volume":"13","author":"Jain","year":"2025","journal-title":"J Pediatr Soc North Am"},{"issue":"1","key":"10.1016\/j.cps.2026.05.004_bib29","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3475","article-title":"Clinical practice guideline for the management of infantile hemangiomas","volume":"143","author":"Krowchuk","year":"2019","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.cps.2026.05.004_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30779","article-title":"Treatment practices and response in kaposiform hemangioendothelioma: a multicenter cohort study","volume":"71","author":"Borst","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.cps.2026.05.004_bib31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.dld.2024.10.001","article-title":"Blue rubber bleb nevus syndrome: a European multicenter cohort study","volume":"57","author":"Becq","year":"2025","journal-title":"Dig Liver Dis"},{"issue":"Suppl 3","key":"10.1016\/j.cps.2026.05.004_bib32","article-title":"How we approach the diagnosis and management of complex lymphatic anomalies","volume":"69","author":"Ricci","year":"2022","journal-title":"Pediatr Blood Cancer"}],"container-title":["Clinics in Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094129826000374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094129826000374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:48:47Z","timestamp":1788295727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094129826000374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0094129826000374"],"URL":"https:\/\/doi.org\/10.1016\/j.cps.2026.05.004","relation":{},"ISSN":["0094-1298"],"issn-type":[{"value":"0094-1298","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical Management of Vascular Anomalies","name":"articletitle","label":"Article Title"},{"value":"Clinics in Plastic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cps.2026.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}